Predicting loss of hepatitis B surface antigen and evaluating the durability of functional cure induced by pegylated interferon alpha: insights from a real-world study

These results provide valuable insights for predicting responses to Peg-IFN-αtherapy and identifying high-risk groups for HBsAg-RS following HBsAg loss. This information may help refine strategies for achieving and maintaining HBsAg loss and guide post-HBsAg loss monitoring and management procedures.